Transcriptome instability
Transcriptome Instability (TIN) is a phenomenon observed in the genomics field, particularly within the study of cancer and other diseases, where the RNA transcripts of a genome exhibit high levels of variability and alterations. This instability can lead to significant changes in the gene expression profiles of cells, affecting their function and contributing to disease progression.
Overview[edit | edit source]
Transcriptome instability refers to the alterations in the transcriptome, the complete set of RNA transcripts produced by the genome under specific circumstances or in a specific cell. These alterations can include changes in the levels of mRNA expression, the presence of novel or aberrant transcripts, variations in splicing patterns, and alterations in non-coding RNAs. TIN is a hallmark of many cancers, where it can lead to the misregulation of genes critical for cell growth, apoptosis, and DNA repair, thereby promoting tumorigenesis.
Causes of Transcriptome Instability[edit | edit source]
Several factors can contribute to transcriptome instability, including:
- Genetic mutations that affect RNA polymerase, splicing machinery, or other components of the transcriptional machinery.
- Alterations in the epigenome, such as changes in DNA methylation or histone modification patterns, which can affect gene expression.
- Environmental stressors, such as oxidative stress, radiation, and chemical exposure, which can induce DNA damage and affect transcription.
- Viral infections that interfere with normal cellular processes and gene expression.
Consequences of Transcriptome Instability[edit | edit source]
The consequences of transcriptome instability are diverse and can significantly impact cell function and viability. In the context of cancer, TIN can lead to:
- The overexpression or underexpression of oncogenes and tumor suppressor genes, respectively.
- The production of aberrant proteins that may promote cell proliferation, inhibit apoptosis, or enhance metastasis.
- Increased genetic and phenotypic diversity within tumor populations, contributing to drug resistance and treatment failure.
Detection and Analysis[edit | edit source]
Techniques used to detect and analyze transcriptome instability include:
- RNA sequencing (RNA-seq), which provides a comprehensive view of the transcriptome and can identify novel transcripts and splicing events.
- Microarray analysis, although less commonly used now, can still provide insights into changes in gene expression levels.
- Quantitative PCR (qPCR) for the validation of specific changes in transcript levels identified by other methods.
Therapeutic Implications[edit | edit source]
Understanding and targeting the mechanisms underlying transcriptome instability may offer new avenues for cancer therapy. Strategies may include:
- Developing drugs that specifically target the aberrant transcriptional machinery or splicing factors.
- Using epigenetic therapy to reverse the epigenetic changes contributing to TIN.
- Enhancing the cell's ability to repair DNA damage and maintain genomic integrity.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD